Clinical Trial: a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166796) titled 'a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects' on Aug. 25.

Brief Summary: Tolvaptan oral administraction phase I PK clinical trial. Two groups of healthy male subjects. One group receives single dose of Tolvaptan. The other group receives multi dose of Tolvaptan.

Study Start Date: Oct. 01, 2006

Study Type: INTERVENTIONAL

Condition: Health Subjects

Intervention: DRUG: singe dose 15mg

succesfule screened subject, take single dose of 15mg Tolvaptan tablet with no feeding.

DRUG: single dose 30mg

succesfule screened subject, take single dose of 30mg Tolvaptan tablet with no feeding.

DRUG: singl...